Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 37 | 34 | −3 |
| Shares | 3.45M | 3.11M | −345.3K (−10.0%) |
| Value | $10.7M | $11.8M | +$1.07M (+9.9%) |
New holders (3)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 21,247 | $80.7K | 0.00% |
| Virtu Financial LLC | 10,153 | $39.0K | 0.00% |
| Belvedere Trading LLC | 991 | $3.77K | 0.00% |
Sold out (6)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Alpha Square Group S, LLC | 33,401 | $103.9K |
| HRT Financial LP | 22,587 | $70.0K |
| RSM US Wealth Management LLC | 19,813 | $61.6K |
| Activest Wealth Management | 9,800 | $30.5K |
| Wells Fargo & Company | 103 | $320 |
| Barclays PLC | 39 | $121 |